Draghia-Akli Ruxandra (CIK 2041719) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy NVAX (26,667 shares), Sell NVAX (11,313 shares), Buy NVAX (14,257 shares), Sell NVAX (6,048 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NOVAVAX INC (NVAX) | EVP, Research & Development | Buy | 26,667 | $0 |
| 2026-03-05 | NOVAVAX INC (NVAX) | EVP, Research & Development | Sell | 11,313 | $107,360 |
| 2025-11-13 | NOVAVAX INC (NVAX) | Section 16 | Buy | 14,257 | $0 |
| 2025-11-13 | NOVAVAX INC (NVAX) | Section 16 | Sell | 6,048 | $44,755 |
Source: SEC Form 4 filings · as of 2026-03-05